Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study Evaluating the Safety and Efficacy of bb1111 in Severe Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02140554
Recruitment Status : Active, not recruiting
First Posted : May 16, 2014
Last Update Posted : July 19, 2022
Information provided by (Responsible Party):
bluebird bio